GPX3 promotes cisplatin resistance in TNBC by manipulating ROS-TGFB1-ZEB2
Abstract Background Due to the lack of effective targeted therapies and the high likelihood of acquired resistance, triple-negative breast cancer (TNBC) remains one of the deadliest cancers affecting women globally. Investigating the mechanism underlying TNBC’s resistance to platinum-based chemother...
Saved in:
| Main Authors: | Qingyi Hu, Qianzhi Chen, Wen Yang, Anwen Ren, Jie Tan, Tao Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Cell Communication and Signaling |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12964-025-02356-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth
by: Alessandra Caliendo, et al.
Published: (2025-08-01) -
A cisplatin prodrug-based self-assembling ozone delivery nanosystem sensitizes radiotherapy in triple-negative breast cancer
by: Tianyue Xu, et al.
Published: (2025-05-01) -
E2F-1–Akt1 Interaction as Precursor to Cisplatin-induced Apoptosis in Triple-negative Breast Cancer Cells
by: Samiya Al-Jaaidi, et al.
Published: (2025-01-01) -
Narciclasine enhances cisplatin-induced apoptotic cell death by inducing unfolded protein response-mediated regulation of NOXA and MCL1
by: Ji Hae Lee, et al.
Published: (2025-05-01) -
The search for a TNBC vaccine: the guardian vaccine
by: Cory Fines, et al.
Published: (2025-12-01)